Ankerstar Wealth’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Ankerstar Wealth's KRYS Position: Q3 2026 in Review
Ankerstar Wealth sold out of Krystal Biotech (KRYS) in Q3 2026, closing a stake of 4 shares — an estimated $1.49K sold.
Ankerstar Wealth first reported a position in KRYS in Q4 2025 and held it in 3 quarters. The position peaked at $1.49K in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Ankerstar Wealth reported no remaining Krystal Biotech position as of Q3 2026 after selling out during the quarter.
- Ankerstar Wealth sold 4 Krystal Biotech shares in Q3 2026, an estimated $1.49K.
- Ankerstar Wealth first reported a position in Krystal Biotech in Q4 2025 and held it in 3 quarters.
- Ankerstar Wealth's Krystal Biotech position peaked at $1.49K in Q2 2026.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.